ATE257332T1 - Vitamin formulierung für kardiovaskuläre gesundheit - Google Patents

Vitamin formulierung für kardiovaskuläre gesundheit

Info

Publication number: ATE257332T1
Authority: AT; Austria
Prior art keywords: cardiovascular health; vitamin; vitamin formulation; composition; high level
Prior art date: 1999-03-18

Application number

AT00200967T

Other languages

English (en)

Inventor

Atef Boulos

Jatin Desai

Neil Martin

Robert Stillman

Marion Udwin

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-18

Filing date

2000-03-16

Publication date

2004-01-15

2000-03-16 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2004-01-15 Application granted granted Critical

2004-01-15 Publication of ATE257332T1 publication Critical patent/ATE257332T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
230000036996 cardiovascular health Effects 0.000 title abstract 2
229930003231 vitamin Natural products 0.000 title abstract 2
229940088594 vitamin Drugs 0.000 title abstract 2
235000013343 vitamin Nutrition 0.000 title abstract 2
239000011782 vitamin Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
150000003722 vitamin derivatives Chemical class 0.000 title 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
229930003427 Vitamin E Natural products 0.000 abstract 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
229940046009 vitamin E Drugs 0.000 abstract 2
235000019165 vitamin E Nutrition 0.000 abstract 2
239000011709 vitamin E Substances 0.000 abstract 2
239000007894 caplet Substances 0.000 abstract 1
230000006835 compression Effects 0.000 abstract 1
238000007906 compression Methods 0.000 abstract 1
229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
239000011707 mineral Substances 0.000 abstract 1
150000004760 silicates Chemical class 0.000 abstract 1
239000003826 tablet Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT00200967T 1999-03-18 2000-03-16 Vitamin formulierung für kardiovaskuläre gesundheit ATE257332T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27181099A	1999-03-18	1999-03-18
US51251200A	2000-02-24	2000-02-24

Publications (1)

Publication Number	Publication Date
ATE257332T1 true ATE257332T1 (de)	2004-01-15

Family

ID=26955120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00200967T ATE257332T1 (de)	1999-03-18	2000-03-16	Vitamin formulierung für kardiovaskuläre gesundheit

Country Status (7)

Country	Link
EP (1)	EP1036510B1 (de)
JP (1)	JP2000281574A (de)
CN (1)	CN1271579A (de)
AT (1)	ATE257332T1 (de)
AU (1)	AU2232300A (de)
BR (1)	BR0001343A (de)
DE (1)	DE60007576D1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1216713A1 (de) *	2000-12-20	2002-06-26	Schering Aktiengesellschaft	Zusammensetzungen von Estrogen-Zyklodextrin Komplexe
FR2821748A1 (fr) *	2001-03-12	2002-09-13	Laurent Schwartz	Utilisation d'un principe actif anti-fibrose pour la preparation d'un medicamment destine a la prevention du cancer broncho-pulmonaire
JP4755353B2 (ja) *	2001-04-02	2011-08-24	興和株式会社	ビタミンｂ１製剤
US6436431B1 (en) *	2001-07-02	2002-08-20	Diane Wright Hoffpauer	Fortified rice bran food product and method for promoting cardiovascular health
JP4965096B2 (ja) *	2005-08-19	2012-07-04	テバ製薬株式会社	圧縮成型製剤
JP5249568B2 (ja) *	2007-12-06	2013-07-31	旭化成ケミカルズ株式会社	成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法
CN102264222B (zh) *	2008-11-04	2014-12-10	威麦迪克有限责任公司	抗病毒补剂
RU2663017C2 (ru) *	2009-01-23	2018-08-01	ВАЙЕТ ЭлЭлСи	Пищевые добавки для лиц в возрасте 50 лет и старше для повышения жизнеспособности, иммунитета, здоровья глаз и костей
EP2389177A1 (de) *	2009-01-23	2011-11-30	Wyeth LLC	Multivitamin-/mineralformulierung zur bekämpfung der auswirkungen von umweltstress, verbesserung der immunität und erhöhung der energie bei gleichzeitiger behandlung von vitamin- und mineralmangel ohne negative nebenwirkungen einer nahrungsergänzung in hohen dosen
EP2545788A1 (de) *	2011-07-13	2013-01-16	Martin Hulliger	Diätisches Mehrkomponentensystem
CN106901378A (zh) *	2017-03-10	2017-06-30	深圳奥萨医疗有限公司	一种适用于女性的保健食品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2858215A (en) *	1956-07-02	1958-10-28	Barnett Lab Inc	Process of preparing vitamin oils in particle form
US4603143A (en) *	1983-05-02	1986-07-29	Basf Corporation	Free-flowing, high density, fat soluble vitamin powders with improved stability
US4617294A (en) *	1985-04-22	1986-10-14	Ppg Industries, Inc.	Animal feed supplement
KR19980703596A (ko) *	1990-10-01	1998-12-05	쉘비 캘버트 모스	주요 혈관 이상 상태를 억제하기 위한 베타-카로틴 및 비타민 e 치료법
JP4494539B2 (ja) *	1997-02-28	2010-06-30	ディーエスエムアイピーアセッツビー．ブイ．	流動自由な乾燥粒子

2000
- 2000-03-16 DE DE60007576T patent/DE60007576D1/de not_active Expired - Lifetime
- 2000-03-16 EP EP00200967A patent/EP1036510B1/de not_active Expired - Lifetime
- 2000-03-16 AT AT00200967T patent/ATE257332T1/de not_active IP Right Cessation
- 2000-03-17 AU AU22323/00A patent/AU2232300A/en not_active Abandoned
- 2000-03-17 JP JP2000081764A patent/JP2000281574A/ja active Pending
- 2000-03-17 BR BR0001343-9A patent/BR0001343A/pt not_active IP Right Cessation
- 2000-03-17 CN CN00106740A patent/CN1271579A/zh active Pending

Also Published As

Publication number	Publication date
EP1036510A2 (de)	2000-09-20
EP1036510B1 (de)	2004-01-07
AU2232300A (en)	2000-09-21
DE60007576D1 (de)	2004-02-12
JP2000281574A (ja)	2000-10-10
BR0001343A (pt)	2001-08-14
CN1271579A (zh)	2000-11-01
EP1036510A3 (de)	2000-11-08

Similar Documents

Publication	Publication Date	Title
WO2003059274A3 (en)	2004-01-15	Vitamin formulation for cardiovascular health
DE60007576D1 (de)	2004-02-12	Vitamin Formulierung für kardiovaskuläre Gesundheit
HUP0303621A3 (en)	2005-03-29	Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone
EP0960621A3 (de)	2000-01-05	Pharmazeutische Zusammensetzungen enthaltend sildenafil
EE200100618A (et)	2003-02-17	Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks
HUP0301577A3 (en)	2006-02-28	Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
IL128942A0 (en)	2000-02-17	Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and pharmaceutical compositions containing the same
PL368610A1 (en)	2005-04-04	Orodispersible tablets containing fexofenadine
AP2001002125A0 (en)	2001-04-04	Controlled-rease pharmaceutical formulations.
HUP0104768A3 (en)	2002-05-28	4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
HUP0302160A3 (en)	2005-05-30	Pharmaceutical compositions containing the combination of gaba agonists and sorbitol dehydrogenase inhibitors
IL158671A0 (en)	2004-05-12	Benzyloxy derivatives and pharmaceutical compositions containing the same
ES2052802T3 (es)	1994-07-16	Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina.
ES2124736T3 (es)	1999-02-16	Comprimidos con alto contenido de clorhidrato de colestipol.
MXPA03003795A (es)	2003-08-20	Formulaciones autoemulsionantes de dosis orales de inhibidores de proteasa de tipo piranona.
EP1492510A4 (de)	2006-01-11	Niedrigdosierte flüssige entecavir-formulierungen und verwendung
ES2164753T3 (es)	2002-03-01	Tabletas organolepticamente estables para la limpieza de dentaduras.
AR040737A1 (es)	2005-04-20	Administracion oral de calcitonina
IL151197A0 (en)	2003-04-10	Thiazepinyl hydroxamic acid derivatives and pharmaceutical compositions containing the same
MXPA00002462A (es)	2004-10-28	Formulacion de vitamina para la salud cardiovascular.
HUP0203118A3 (en)	2003-05-28	Beta disubstituted metalloprotease inhibitors, pharmaceutical compositions containing them and their use
AU2001277786A1 (en)	2002-02-18	Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase
BR0100651A (pt)	2001-12-04	Recipiente para o recebimento de um produto derestauração e um método para sua fabricação
ATE269061T1 (de)	2004-07-15	Calciumhaltige brausetablette mit einem antihistaminikum als wirkstoff
SG153894G (en)	1995-03-17	Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Legal Events

Date	Code	Title	Description
2004-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties